Many investigations have revealed that inflammation significantly contributes to cancer progression, and the NLRP3 inflammasome is considered to be involved in this process due to its induction of pro-inflammatory cytokines, such as IL-1β and IL-18, and its activation of critical inflammatory signaling cascades, including the NF-κB pathway [86]. This evidence concerns the gene NLRP3 and cancer.